Knowles (KN) 16th Annual East Coast IDEAS Conference summary
Event summary combining transcript, slides, and related documents.
16th Annual East Coast IDEAS Conference summary
12 Jun, 2026Business transformation and market focus
Underwent significant transformation, divesting low-margin assets and acquiring high-value businesses, resulting in a focus on MedTech, defense, and industrial markets.
Now operates in two main segments: Precision Devices (specialty capacitors and RF filters) and MedTech & Specialty Audio (hearing health microphones and speakers).
MedTech and defense markets are resilient and non-cyclical, providing insulation from broader economic cycles.
Precision Devices segment grew 16%-17% YoY last quarter; MedTech & Specialty Audio up 14% YoY in Q1.
Transformation included divesting consumer MEMS microphones and commodity businesses, with no further divestitures planned.
Financial performance and outlook
Achieved nearly $600 million in revenue last year, with strong EBITDA and cash flow margins.
Consensus for 2026 is $640-$645 million in revenue (8%+ growth) and $160 million EBITDA (14% growth).
Six consecutive quarters of book-to-bill over one in Precision Devices; strong April bookings.
Cash from operations averages 20% of revenue; leverage ratio expected to approach zero by end of 2026.
EBITDA margin currently at 25%, with a path to 30% over 3-4 years through gross margin expansion and operating leverage.
Capital allocation and M&A strategy
Repurchased $210 million in shares since 2022 at an average price of $19; current share price over $30.
CapEx typically 3%-5% of revenue, with recent years at the high end due to capacity expansion.
Acquired Cornell Dubilier for $263 million in 2023, a highly successful deal with significant revenue and margin growth.
Future M&A targets include consolidation, extensions (new applications), and adjacencies (e.g., inductors, resistors, magnetics).
Will not exceed 2.75x leverage for acquisitions; focus on $10-$30 million EBITDA targets.
Latest events from Knowles
- Q1 2026 revenue rose 16% to $153.1M, with 50% EPS growth and strong segment margins.KN
Q1 202628 Apr 2026 - Q4 and full year results surpassed guidance, with strong growth and positive 2026 outlook.KN
Q4 202512 Apr 2026 - Annual meeting covers director elections, executive pay, and auditor ratification for 2026.KN
Proxy Filing11 Mar 2026 - 2026 proxy covers director elections, executive pay, auditor ratification, and robust governance.KN
Proxy Filing11 Mar 2026 - Portfolio shift to MedTech, defense, and industrial boosts margins and growth outlook.KN
2024 Southwest IDEAS Conference3 Feb 2026 - Targets 8–10% annual revenue growth and 10–14% EBITDA growth through organic and M&A strategies.KN
Investor Day 20253 Feb 2026 - Q2 revenue up 18.3% to $204.7M; $249.4M goodwill impairment drove $259M net loss.KN
Q2 20242 Feb 2026 - Q3 revenue up 32% year-over-year; strategic divestiture and margin gains position for growth.KN
Q3 202418 Jan 2026 - Q1 2025 revenue hit $132.2M, with strong cash flow and robust Precision Devices demand.KN
Q1 202526 Dec 2025